Katsuto Shinohara, MD
Katsuto Shinohara, MD
Katsuto Shinohara, MD is a native of Japan. He attended Yokohama City University School of Medicine and graduated with highest honors. He received three years of general surgery training at Mitsui Memorial Hospital in Tokyo and completed his urology residency at Kitasato University Hospital in Sagamihara, Japan. He came to the United States in 1984 as a urologic oncology fellow at Baylor College of Medicine in Houston, Texas. After completing the fellowship in 1988, he joined the faculty in the UCSF Department of Urology.
Shinohara is currently professor of urology at UCSF and an attending surgeon at the Department of Veterans Affairs Medical Center in San Francisco. He is a member of the American Urological Association, the Japanese Urological Association, Society of Urological Oncology, American Society for Radiation Oncology and the American Institute of Ultrasound in Medicine. Shinohara is an expert in prostate imaging and prostate cancer diagnosis. Shinohara is interested in interventional therapy of prostate diseases.
Tissue Ablation of the Prostate Gland and Focal Therapy of Prostate Cancer
Various energy sources, such as freezing, laser, highly focused ultrasound and microwaves, have been used to ablate prostate tissue to treat symptomatic benign prostatic hyperplasia. These techniques can also be used as a form of focal tissue ablation to treat prostate cancer. Current areas of research include technical innovations, controlling the energy source, and optimum patient selection for these treatments.
Brachytherapy of Prostate Cancer
With Mack Roach III, MD and I-Chow Hsu, MD in the UCSF Radiation Oncology Deparatment, Shinohara has developed a joint program of brachy therapy (radioactive seed implantation and high-dose rate radiation therapy) as a prostate cancer treatment. Ongoing research stemming from this program includes evaluation of outcomes and further development of technical innovations.
Early Detection of Prostate Cancer
A cohort of patients who underwent prostate biopsies are retrospectively analyzed based on PSA, PSA density, ultrasound findings, number and location of prostate biopsies, and ethnic background, in order to optimize the cancer detection rate.
1825 4th Street
6th floor Baker Precision Cancer Medicine Building
San Francisco, CA 94158
Nurse Navigator for general questions
regarding making an appointment
New Patient Coordinator
University of California, San Francisco
Department of Urology, Mailcode 1695
550 16th Street, 6th Floor
San Francisco, CA 94143